$FOMI
FORMATION MINERALS, INC. Stock $fomi

$fomi Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-K Financial Statement

#000121390023067158 Filed on August 14, 2023

Income Statement

Concept	2023 Q3	2023
Revenue	$335.00	$4.417K
YoY Change	-91.03%	-31.24%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$141.9K	$617.2K
YoY Change		-29.76%
% of Gross Profit
Research & Development	$6.914K	$161.9K
YoY Change		-1.95%
% of Gross Profit
Depreciation & Amortization	$15.48K
YoY Change
% of Gross Profit
Operating Expenses	$6.914K	$161.9K
YoY Change		-1.95%
Operating Profit	-$148.8K	-$779.1K
YoY Change	-17.91%	-25.36%
Interest Expense	$2.041K	$8.273K
YoY Change	-4.49%	-18.75%
% of Operating Profit
Other Income/Expense, Net	$10.16K
YoY Change
Pretax Income	-$150.5K	-$783.0K
YoY Change	-16.23%	-25.26%
Income Tax
% Of Pretax Income
Net Earnings	-$148.9K	-$766.1K
YoY Change	-16.44%	-17.62%
Net Earnings / Revenue	-44438.21%	-17343.4%
Basic Earnings Per Share	$0.00	-$0.01
Diluted Earnings Per Share	$0.00	-$0.01
COMMON SHARES
Basic Shares Outstanding	56.35M shares	87.65M shares
Diluted Shares Outstanding	5.363M shares	87.65M shares

Balance Sheet

Concept	2023 Q3	2023 Q2	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$12.19K		$26.79K
YoY Change			-42.29%
Cash & Equivalents	$12.19K	$26.96K
Short-Term Investments
Other Short-Term Assets	$13.02K		$12.86K
YoY Change			-96.73%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$25.20K	$39.65K	$39.65K
YoY Change	-90.99%	-90.98%	-90.98%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$0.00	$0.00	$0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets	$25.20K	$39.65K	$39.65K
Total Long-Term Assets	$0.00	$0.00	$0.00
Total Assets	$25.20K	$39.65K	$39.65K
YoY Change	-90.99%	-90.98%	-90.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$538.5K		$540.7K
YoY Change			17.71%
Accrued Expenses	$63.50K	$52.00K	$52.00K
YoY Change	-0.42%	-20.87%	-20.86%
Deferred Revenue
YoY Change
Short-Term Debt	$80.96K	$82.82K	$196.2K
YoY Change			20.28%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.142M	$1.101M	$1.101M
YoY Change	27.52%	24.45%	24.45%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00		$0.00
YoY Change			-100.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00		$0.00
YoY Change			-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.142M	$1.101M	$1.101M
Total Long-Term Liabilities	$0.00		$0.00
Total Liabilities	$1.142M	$1.101M	$1.143M
YoY Change	27.52%	21.97%	5242.52%
SHAREHOLDERS EQUITY
Retained Earnings	-$6.176M	-$6.027M
YoY Change	12.39%	35.95%
Common Stock	$1.084M	$1.073M
YoY Change	85.02%	74.91%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$1.339M	-$1.284M	-$1.104M
YoY Change
Total Liabilities & Shareholders Equity	$25.20K	$39.65K	$39.65K
YoY Change	-90.99%	-90.98%	-90.98%

Cashflow Statement

Concept	2023 Q3	2023
OPERATING ACTIVITIES
Net Income	-$148.9K	-$766.1K
YoY Change	-16.44%	-17.62%
Depreciation, Depletion And Amortization	$15.48K
YoY Change
Cash From Operating Activities	-$17.85K	-$435.4K
YoY Change	-88.54%	-31.12%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	$329.9K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$0.00
YoY Change		-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		$40.02K
YoY Change		-89.13%
NET CHANGE
Cash From Operating Activities	-$17.85K	-$435.4K
Cash From Investing Activities	$329.9K
Cash From Financing Activities		$40.02K
Net Change In Cash	-$14.77K	-$410.2K
YoY Change	-90.76%	56.21%
FREE CASH FLOW
Cash From Operating Activities	-$17.85K	-$435.4K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q2	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q2	us-gaap	Stockholders Equity Note Subscriptions Receivable StockholdersEquityNoteSubscriptionsReceivable		usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-04-30
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--04-30
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-39946
CY2023	dei	Entity Registrant Name EntityRegistrantName	SENSASURE TECHNOLOGIES, INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-2406468
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	4730 S. Fort Apache Rd.
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 300
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Las Vegas
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	NV
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	89147
CY2023	dei	City Area Code CityAreaCode	(347)
CY2023	dei	Local Phone Number LocalPhoneNumber	325-4677
CY2023	dei	Security12b Title Security12bTitle	Common Stock, par value $0.01 per share
CY2023	dei	Trading Symbol TradingSymbol	SSTC
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	56349183	shares
CY2023	dei	Auditor Name AuditorName	Fruci & Associates II, PLLC
CY2023	dei	Auditor Firm AuditorFirmId	5525
CY2023	dei	Auditor Location AuditorLocation	Spokane, Washington
CY2023Q2	us-gaap	Cash Cash	26786	usd
CY2022Q2	us-gaap	Cash Cash	46419	usd
CY2023Q2	us-gaap	Assets Held In Trust Current AssetsHeldInTrustCurrent	172	usd
CY2022Q2	us-gaap	Assets Held In Trust Current AssetsHeldInTrustCurrent	390758	usd
CY2023Q2	sesu	Prepayments And Other Receivables PrepaymentsAndOtherReceivables	12688	usd
CY2022Q2	sesu	Prepayments And Other Receivables PrepaymentsAndOtherReceivables	2468	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	39646	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	439645	usd
CY2023Q2	us-gaap	Assets Assets	39646	usd
CY2022Q2	us-gaap	Assets Assets	439645	usd
CY2023Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	105868	usd
CY2022Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	117892	usd
CY2023Q2	sesu	Accounts Payable And Accrued Liabilities To A Related Party AccountsPayableAndAccruedLiabilitiesToARelatedParty	486826	usd
CY2022Q2	sesu	Accounts Payable And Accrued Liabilities To A Related Party AccountsPayableAndAccruedLiabilitiesToARelatedParty	407163	usd
CY2023Q2	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	113375	usd
CY2022Q2	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	76638	usd
CY2023Q2	us-gaap	Loans Payable Current LoansPayableCurrent	82823	usd
CY2022Q2	us-gaap	Loans Payable Current LoansPayableCurrent	86482	usd
CY2023Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	312347	usd
CY2022Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	196740	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	1101239	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	884915	usd
CY2022Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable	17935	usd
CY2023Q2	us-gaap	Liabilities Liabilities	1101239	usd
CY2022Q2	us-gaap	Liabilities Liabilities	902850	usd
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	56349183	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	105723183	shares
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	425431	usd
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	609351	usd
CY2023Q2	us-gaap	Shares Issued SharesIssued	804000	shares
CY2023Q2	sesu	Common Stock Value1 CommonStockValue1	15755	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	4533073	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	4197213	usd
CY2023Q2	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	-231505	usd
CY2022Q2	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	-195610	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-6027209	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-4433352	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-1284455	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	177602	usd
CY2023Q2	us-gaap	Noncontrolling Interest In Variable Interest Entity NoncontrollingInterestInVariableInterestEntity	42061	usd
CY2022Q2	us-gaap	Noncontrolling Interest In Variable Interest Entity NoncontrollingInterestInVariableInterestEntity	-881448	usd
CY2023Q2	us-gaap	Statutory Accounting Practices Statutory Capital And Surplus Balance StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance	180801	usd
CY2022Q2	us-gaap	Statutory Accounting Practices Statutory Capital And Surplus Balance StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance	240641	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1061593	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-463205	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	39646	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	439645	usd
CY2023	us-gaap	Revenues Revenues	4417	usd
CY2022	us-gaap	Revenues Revenues	6424	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	617175	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	878712	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	161922	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	165139	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-779097	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-1043851	usd
CY2023	us-gaap	Interest Expense InterestExpense	8273	usd
CY2022	us-gaap	Interest Expense InterestExpense	10182	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-782953	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1047609	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-782953	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-1047609	usd
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-16895	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-117648	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-766058	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-929961	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.009
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.015
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	87645057	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	61379022	shares
CY2023	us-gaap	Profit Loss ProfitLoss	-782953	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-1047609	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	16825	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	120726	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-766128	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-926883	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	766058	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	929961	usd
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-15737	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-89336	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest	-16895	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest	-117648	usd
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-1088	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-31390	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-766128	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-926883	usd
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-113692	usd
CY2022	sesu	Issuance Of Shares Pursuant To Private Placement IssuanceOfSharesPursuantToPrivatePlacement	340900	usd
CY2022	sesu	Amortization Of Vested Share AmortizationOfVestedShare	88210	usd
CY2022	sesu	Issuance Of Shares For Servicesin Share IssuanceOfSharesForServicesinShare	148260	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-1047609	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	120726	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-463205	usd
CY2023	sesu	Subsidiary Issuance Of Shares Pursuant To Private Placement SubsidiaryIssuanceOfSharesPursuantToPrivatePlacement	45	usd
CY2023	sesu	Amortization Of Vested Share AmortizationOfVestedShare	36440	usd
CY2023	sesu	Issuance Of Common Shares For Service IssuanceOfCommonSharesForService	131255	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-782953	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	16825	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1061593	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-782953	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-1047609	usd
CY2023	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	36440	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	88210	usd
CY2023	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	131255	usd
CY2022	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	148260	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-549	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	10146	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-3728	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	83310	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	196586	usd
CY2023	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	123596	usd
CY2022	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	174423	usd
CY2023	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	-16877	usd
CY2022	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	-196266	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-435375	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-632119	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	368200	usd
CY2023	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	45	usd
CY2023	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	39979	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	40024	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	368200	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-14868	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1319	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-410219	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-262600	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	437177	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	699777	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	26958	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	437177	usd
CY2020Q4	sesu	Description Of Share Exchange Agreement DescriptionOfShareExchangeAgreement	the Company completed a reverse recapitalization via a share exchange agreement with Sensa Bues AB and the shareholders who owned 270,339 common shares that represented 72.82% of the total issued and outstanding common shares in Sensa Bues AB. Under the share exchange agreement, the shareholders of Sensa Bues AB, agreed to exchange their shares of Sensa Bues AB for common shares of SensaSure at an exchange ratio of approximate 1:49.99. Pursuant to the share exchange transactions (see share exchange agreement noted above), SensaSure issued a total of 13,515,183 common shares and the then-shareholders of Sensa Bues AB hold their ownership of Sensa Bues AB through SensaSure (Note 9 (b)). Upon completion of the share exchange transaction, SensaSure became the controlling shareholder that owned 74.82% the total issued and outstanding common shares in Sensa Bues AB and parent company of Sensa Bues AB (“Subsidiary”).
CY2023Q2	sesu	Common Stock Share Issued CommonStockShareIssued	2200000	shares
CY2023	sesu	Common Shares Noncontrolling Interests CommonSharesNoncontrollingInterests	440	shares
CY2023Q2	sesu	Working Capital Deficiency WorkingCapitalDeficiency	1061593	usd
CY2022Q2	sesu	Working Capital Deficiency WorkingCapitalDeficiency	445270	usd
CY2022Q2	sesu	Several Private Placements SeveralPrivatePlacements	368200	usd
CY2021Q2	sesu	Several Private Placements SeveralPrivatePlacements	893014	usd
CY2021Q1	us-gaap	Gas Imbalance Payable Current And Noncurrent GasImbalancePayableCurrentAndNoncurrent	333744	usd
CY2021Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	326337	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px; text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</span></td> <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Critical management judgment and use of estimates</b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of the consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Areas involving significant estimates and assumptions include: deferred income tax assets and related valuation allowance, accruals, stock options, principles of consolidation and reverse recapitalization and assumptions used in the going concern assessment. Actual results could differ from those estimates. These estimates are reviewed periodically, and, as adjustments become necessary, they are reported in earnings in the period in which they become known.</p>
CY2021	sesu	Proceeds Net ProceedsNet	793000	usd
CY2021	sesu	Proceed From Issuance Of Common Stock ProceedFromIssuanceOfCommonStock	12200000	shares
CY2021	sesu	Issued Of Common Shares IssuedOfCommonShares	11780000	shares
CY2023Q2	sesu	Proceeds Received In Common Stock ProceedsReceivedInCommonStock	117800	usd
CY2023Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	647900	usd
CY2021Q2	us-gaap	Common Stock Share Subscribed But Unissued Subscriptions Receivable CommonStockShareSubscribedButUnissuedSubscriptionsReceivable	27300	usd
CY2023	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	420000	shares
CY2022	sesu	Subscription Proceeds Received SubscriptionProceedsReceived	420000	shares
CY2023Q2	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	53868	usd
CY2022Q2	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	52178	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	52000	usd
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	65714	usd
CY2023Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	105868	usd
CY2022Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	117892	usd
CY2023Q2	us-gaap	Redeemable Noncontrolling Interest Equity Fair Value RedeemableNoncontrollingInterestEquityFairValue	28550	usd
CY2023Q2	us-gaap	Redeemable Noncontrolling Interest Equity Fair Value RedeemableNoncontrollingInterestEquityFairValue	293000	sek
CY2022Q2	us-gaap	Redeemable Noncontrolling Interest Equity Fair Value RedeemableNoncontrollingInterestEquityFairValue	29811	usd
CY2022Q2	us-gaap	Redeemable Noncontrolling Interest Equity Fair Value RedeemableNoncontrollingInterestEquityFairValue	293000	sek
CY2023Q2	us-gaap	Derivative Fixed Interest Rate DerivativeFixedInterestRate	0.20	pure
CY2023	us-gaap	Interest Expense Debt InterestExpenseDebt	5611	usd
CY2022	us-gaap	Interest Expense Debt InterestExpenseDebt	6580	usd
CY2023	us-gaap	Interest Expense Other InterestExpenseOther	881	usd
CY2022	us-gaap	Interest Expense Other InterestExpenseOther	1214	usd
CY2023Q2	us-gaap	Debt Default Longterm Debt Amount DebtDefaultLongtermDebtAmount	39979	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	0.2089	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	0.248	pure
CY2023	us-gaap	Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet	-782953	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet	-1047609	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2089	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.248	pure
CY2023	sesu	Income Tax Recoverable IncomeTaxRecoverable	-163583	usd
CY2022	sesu	Income Tax Recoverable IncomeTaxRecoverable	-259848	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	35216	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	66212	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	31737	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	46991	usd
CY2023Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	96630	usd
CY2022Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	146645	usd
CY2023Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	940687	usd
CY2022Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	812320	usd
CY2023Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	940687	usd
CY2022Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	812320	usd
CY2023	us-gaap	State And Local Income Tax Expense Benefit Continuing Operations StateAndLocalIncomeTaxExpenseBenefitContinuingOperations	4429715	usd
CY2022	us-gaap	State And Local Income Tax Expense Benefit Continuing Operations StateAndLocalIncomeTaxExpenseBenefitContinuingOperations	3814457	usd
CY2021Q1	sesu	Aggregated Shares AggregatedShares	3400	shares
CY2021Q1	sesu	Number Of Common Shares NumberOfCommonShares	50	shares
CY2023Q2	us-gaap	Loans And Leases Receivable Related Parties LoansAndLeasesReceivableRelatedParties	29232	usd
CY2022Q2	us-gaap	Loans And Leases Receivable Related Parties LoansAndLeasesReceivableRelatedParties	30523	usd
CY2023Q2	us-gaap	Loans And Leases Receivable Related Parties LoansAndLeasesReceivableRelatedParties	300000	sek
CY2022Q2	us-gaap	Loans And Leases Receivable Related Parties LoansAndLeasesReceivableRelatedParties	300000	sek
CY2023	sesu	Unsecured Bearing Interest UnsecuredBearingInterest	0.02	pure
CY2022Q2	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	407163	usd
CY2021Q1	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	333744	usd
CY2021Q1	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	798280	sek
CY2022Q2	us-gaap	Other Long Term Debt OtherLongTermDebt	17935	usd
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	56349183	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	105723183	shares
CY2021	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	99643	usd
CY2021	sesu	Common Shares To Noncontrolling Interests CommonSharesToNoncontrollingInterests	10000	shares
CY2021Q2	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	499935	shares
CY2023	us-gaap	Proceeds From Customers ProceedsFromCustomers	4999	usd
CY2023Q2	us-gaap	Common Stocks Including Additional Paid In Capital Net Of Discount CommonStocksIncludingAdditionalPaidInCapitalNetOfDiscount	94644	usd
CY2020Q4	sesu	Owned Common Shares OwnedCommonShares	270339	shares
CY2020Q4	sesu	Owned Common Shares Percentage OwnedCommonSharesPercentage	0.7282	pure
CY2020Q4	us-gaap	Stockholders Equity Note Changes In Capital Structure Subsequent Changes To Number Of Common Shares StockholdersEquityNoteChangesInCapitalStructureSubsequentChangesToNumberOfCommonShares	13515183	shares
CY2020Q4	us-gaap	Accelerated Share Repurchases Cash Or Stock Settlement AcceleratedShareRepurchasesCashOrStockSettlement	Shareholders agreed that from the Effective Date of share exchange agreement the Shareholders shall have up to 243,402 shares to sell when a trading market begins on the OTC Markets. Eighteen (18) months after the initial listing date of the shares on the NASDAQ Market, the Shareholder shall have 1,914,704 shares available to sell. Twenty-four (24) months after the initial listing date of the shares on the NASDAQ Market, the Shareholders shall have 5,744,109 shares available to sell.
CY2021	us-gaap	Proceeds From Other Equity ProceedsFromOtherEquity	793000	usd
CY2021	us-gaap	Restricted Stock Shares Issued Net Of Shares For Tax Withholdings RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings	12200000	shares
CY2021	us-gaap	Stockholders Equity Note Changes In Capital Structure Subsequent Changes To Number Of Common Shares StockholdersEquityNoteChangesInCapitalStructureSubsequentChangesToNumberOfCommonShares	11780000	shares
CY2021	sesu	Agreement Description AgreementDescription	The proceeds received was reflected as an increase in common stock in amount of $117,800 and additional paid-in capital in amount of $647,900 respectively. The Company recognized a subscription receivable in amount of $27,300 as well as shares to be issued at April 30, 2021. The number of shares to be issued was 420,000. The Company received the subscription proceeds subsequently to year end and issued 420,000 common shares accordingly (Note 4). The subscribers entered into lock up agreement pursuant to which (1) The Shareholders shall 1,715,800 of the shares subscribed to sell when a trading market begins on the OTC Markets; (ii) The Shareholders shall have 5,346,000 of their remaining shares available to sell Six (6) months after the initial listing date of the shares on the NASDAQ Market; (iii) The Shareholders shall have their remaining shares for trading Eighteen (18) months after the initial listing date of the shares on the NASDAQ Market; and (iv) In the event the stock does not begin trading on the NASDAQ Market within a period of Thirty-Six (36) months after the execution of the Share Exchange Agreement, the Shareholders shall have up to Thirty Percent (30%) of their remaining shares available to sell after the initial listing date of the shares on the OTC Market. The balance of the Shareholder’s shares shall be available for trading Sixty (60) months after the initial listing date of the shares on the OTC Market (the “Lock Up Period”).
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	1650000	shares
CY2022	sesu	Shares Available Description SharesAvailableDescription	After the revision, the shareholders shall have 10,898,736 shares available to sell upon a trading market begins on OTC Market, 7,738,000 shares available to sell upon six months after a trading market begins on OTC Market, 4,750,000 shares available to sell upon initial listing date on the Nasdaq Market, 6,280,000 shares available to sell upon six months after initial listing date on the Nasdaq Market, 800,000 shares available to sell upon twelve months after initial listing date on the Nasdaq Market, 3,838,213 shares available to sell upon eighteen months after the initial listing date on Nasdaq Market, 6,620,863 shares available to sell upon twenty four months after the initial listing date on Nasdaq Market and the balance of the shareholders’ shares will be available to sell upon sixty months after the initial listing date on Nasdaq Market.
CY2023Q2	sesu	Fair Value Of Shares Issued Amount FairValueOfSharesIssuedAmount	502614	usd
CY2022	sesu	Unvested Shares UnvestedShares	7931000	shares
CY2022Q4	sesu	Unvested Shares UnvestedShares	8587000	shares
CY2023	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	36440	usd
CY2023	us-gaap	Other Expense From Real Estate Partnership Operations OtherExpenseFromRealEstatePartnershipOperations	15950	usd
CY2023Q2	us-gaap	Common Stocks Including Additional Paid In Capital CommonStocksIncludingAdditionalPaidInCapital	20490	usd
CY2021	us-gaap	Stock Issued During Period Shares Conversion Of Units StockIssuedDuringPeriodSharesConversionOfUnits	24371	shares
CY2021	us-gaap	Deferred Compensation Arrangement With Individual Fair Value Of Shares Issued DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued	360795	usd
CY2022Q2	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	21637000	shares
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	216370	usd
CY2022Q4	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	27950000	shares
CY2023Q2	sesu	Common Shares CommonShares	50	shares
CY2021Q2	us-gaap	Common Stock Share Subscribed But Unissued Subscriptions Receivable CommonStockShareSubscribedButUnissuedSubscriptionsReceivable	27300	usd
CY2023	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	420000	shares
CY2022Q2	sesu	Proceeds Received From Common Stock Issued ProceedsReceivedFromCommonStockIssued	420000	shares
CY2022	us-gaap	Payments For Repurchase Of Private Placement PaymentsForRepurchaseOfPrivatePlacement	340900	usd
CY2022	us-gaap	Accelerated Share Repurchases Initial Price Paid Per Share AcceleratedShareRepurchasesInitialPricePaidPerShare	0.07
CY2022	sesu	Agreement Description AgreementDescription	The proceeds received was reflected as an increase in common stock in amount of $48,700 and additional paid-in capital in amount of $292,200 respectively. The subscribers entered into lock up agreement and the shareholders shall have 502,584 shares available to sell upon a trading market begins on OTC Market, 356,484 shares available to sell upon six months after a trading market begins on OTC Market, 218,663 shares available to sell upon initial listing date on the Nasdaq Market, 289,278 shares available to sell upon six months after initial listing date on the Nasdaq Market, 37,012 shares available to sell upon twelve months after initial listing date on the Nasdaq Market, 176,781 shares available to sell upon eighteen months after the initial listing date on Nasdaq Market, 304,862 shares available to sell upon twenty four months after the initial listing date on Nasdaq Market and the balance of the shareholders’ shares will be available to sell upon sixty months after the initial listing date on Nasdaq Market.
CY2022	us-gaap	Common Stock Conversion Basis CommonStockConversionBasis	During the year ended April 30, 2022, the Company approved the issuance of 2,118,000 shares of the common stock to several consultants and directors. The fair value of the share-based compensation was in the amount of $148,260 and was included in the general and admirative expenses as well as a credit made in common stock in amount of 21,180 and additional paid-in capital in amount of 127,080 respectively. The fair value of the shares of common stock issued was determined by using the most recent private placement price at $0.07 per share. One of the consultants is a related party individual and the share awards was 2,100,000 common shares with an amount of 147,000.During the year ended April 30, 2022, SensaSure issued 3,080,000 common stock to a consultant of the Company for services to be provided in future including completion of certain financing projects and regulatory services. The fair value of the shares of common stock issued was determined by using the most recent private placement price at $0.07 per share. At April 30, 2022 and 2023, none of these services were rendered. Accordingly, the Company has not recognized any share based compensation expense during the year.
CY2023Q2	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	54000	shares
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	3780	usd
CY2022Q1	us-gaap	Deferred Compensation Arrangement With Individual Shares Issued DeferredCompensationArrangementWithIndividualSharesIssued	750000	shares
CY2022Q1	us-gaap	Deferred Compensation Arrangement With Individual Common Stock Reserved For Future Issuance DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance	750000	shares
CY2022Q1	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	11975	usd
CY2022Q3	sesu	Common Share CommonShare	2200000	shares
CY2022Q3	us-gaap	Asset Acquisition Consideration Transferred AssetAcquisitionConsiderationTransferred	225641	usd
CY2023Q1	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	8800000	shares
CY2022Q2	sesu	Common Stock Value1 CommonStockValue1		usd
CY2023Q1	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	115500	usd
CY2023Q1	us-gaap	Deferred Compensation Arrangement With Individual Fair Value Of Shares Issued DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued	16500	usd
CY2023Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.07
CY2021Q2	us-gaap	Common Unit Issued CommonUnitIssued	22000000	shares
CY2023	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	35500	usd
CY2023Q2	sesu	Common Shareholders Of The Company Percentage CommonShareholdersOfTheCompanyPercentage	0.9353	pure
CY2022Q2	sesu	Common Shareholders Of The Company Percentage CommonShareholdersOfTheCompanyPercentage	0.74	pure
CY2023Q2	sesu	Noncontrolling Interests Percentage NoncontrollingInterestsPercentage	0.0647	pure
CY2022Q2	sesu	Noncontrolling Interests Percentage NoncontrollingInterestsPercentage	0.26	pure
CY2023	sesu	Net Loss Of Sensa Bues Ab Attributableto The Companys NetLossOfSensaBuesABAttributabletoTheCompanys	-195634	usd
CY2022	sesu	Net Loss Of Sensa Bues Ab Attributableto The Companys NetLossOfSensaBuesABAttributabletoTheCompanys	-334818	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	883768	usd
CY2023	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-1079402	usd
CY2022	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-334818	usd
CY2023Q1	us-gaap	Retained Earnings Appropriated RetainedEarningsAppropriated	59804	usd
CY2022Q2	us-gaap	Retained Earnings Appropriated RetainedEarningsAppropriated	108102	usd
CY2023Q2	us-gaap	Stockholders Equity Note Subscriptions Receivable StockholdersEquityNoteSubscriptionsReceivable		usd
CY2023Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable		usd
CY2022Q2	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q2	sesu	Preferred Stock Value1 PreferredStockValue1		usd
CY2022Q2	sesu	Preferred Stock Value1 PreferredStockValue1		usd
CY2022Q2	us-gaap	Shares Issued SharesIssued		shares
CY2022	sesu	Issuance Of Shares Pursuant To Private Placementin Shares IssuanceOfSharesPursuantToPrivatePlacementinShares		usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities		usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits		usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation Forfeited StockIssuedDuringPeriodValueShareBasedCompensationForfeited		usd
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices		usd
CY2022	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther		usd
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation Forfeited StockIssuedDuringPeriodValueShareBasedCompensationForfeited		usd
CY2023	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther		usd
CY2023	sesu	Effect Of Dilution Of Ownership In Subsidiary Pursuant To Issuance Of Shares EffectOfDilutionOfOwnershipInSubsidiaryPursuantToIssuanceOfShares		usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable		usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2022	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders		usd
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2022Q2	us-gaap	Debt Default Longterm Debt Amount DebtDefaultLongtermDebtAmount		usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Related Party Tax Expense Due To Affiliates Deferred RelatedPartyTaxExpenseDueToAffiliatesDeferred		usd
CY2022	us-gaap	Related Party Tax Expense Due To Affiliates Deferred RelatedPartyTaxExpenseDueToAffiliatesDeferred		usd
CY2023	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction		usd
CY2022	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction		usd
CY2023Q2	us-gaap	Other Long Term Debt OtherLongTermDebt		usd
CY2023Q2	us-gaap	Other Minority Interests OtherMinorityInterests		usd
CY2022Q2	us-gaap	Other Minority Interests OtherMinorityInterests		usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic		usd
CY2021Q2	us-gaap	Option Contract Indexed To Equity Settlement Cash Effect Of Change In Fair Value Of Share OptionContractIndexedToEquitySettlementCashEffectOfChangeInFairValueOfShare		usd
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001885336
CY2022Q4	dei	Entity Public Float EntityPublicFloat	0	usd
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	105723183	shares

Files In Submission

Name	View Source	Status
0001213900-23-067158-index-headers.html	Edgar Link	pending
0001213900-23-067158-index.html	Edgar Link	pending
0001213900-23-067158.txt	Edgar Link	pending
0001213900-23-067158-xbrl.zip	Edgar Link	pending
ex23-1_001.jpg	Edgar Link	pending
f10k2023ex23-1_sensasuretech.htm	Edgar Link	pending
f10k2023ex31-1_sensasuretech.htm	Edgar Link	pending
f10k2023ex31-2_sensasuretech.htm	Edgar Link	pending
f10k2023ex32-1_sensasuretech.htm	Edgar Link	pending
f10k2023_sensasuretech.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_002.jpg	Edgar Link	pending
image_003.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
f10k2023_sensasuretech_htm.xml	Edgar Link	completed
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
sesu-20230430.xsd	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
sesu-20230430_cal.xml	Edgar Link	unprocessable
sesu-20230430_def.xml	Edgar Link	unprocessable
sesu-20230430_lab.xml	Edgar Link	unprocessable
sesu-20230430_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$FOMI
FORMATION MINERALS, INC. Stock $fomi

2023 Q3 Form 10-K Financial Statement

#000121390023067158 Filed on August 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FOMI FORMATION MINERALS, INC. Stock $fomi

2023 Q3 Form 10-K Financial Statement

#000121390023067158 Filed on August 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FOMI
FORMATION MINERALS, INC. Stock $fomi